A One-Time Shot for Type 2 Diabetes? A Biotech Company Is On It
A One-Time Shot for Type 2 Diabetes? A Biotech Company Is On It
What's New · SpokenLayer
July 11, 20238m 8s
Audio is streamed directly from the publisher (dovetail.prxu.org) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Fractyl Health is developing a gene therapy alternative to drugs like Ozempic and Wegovy to control blood sugar and body weight without repeated injections. Thanks for listening to WIRED. Talk to you next time for more stories from WIRED.com and read this story here.
Learn about your ad choices: dovetail.prx.org/ad-choices